27.72% of Alaunos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Alaunos Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2024	MSD Partners L.P.	15,151,516	$1.07M	0.1%	-33.3%	94.402%
2/9/2024	Commerce Bank	437,000	$31K	0.0%	-4.8%	2.723%
2/2/2024	Magnolia Capital Advisors LLC	401,507	$28K	0.0%	-7.3%	0.167%
11/4/2023	Magnolia Capital Advisors LLC	432,969	$56K	0.1%	N/A	0.180%
7/20/2023	Allred Capital Management LLC	253,000	$0.13M	0.1%	+24.6%	0.105%
5/12/2023	CIBC Private Wealth Group LLC	50,400	$32K	0.0%	+65.8%	0.021%
4/21/2023	Chiron Capital Management LLC	81,830	$52K	0.0%	-22.7%	0.034%
2/15/2023	Allred Capital Management LLC	193,000	$0.13M	0.1%	+22.2%	0.089%
2/14/2023	Discovery Capital Management LLC CT	16,185,998	$10.51M	1.5%	+10.5%	7.487%
2/13/2023	GSA Capital Partners LLP	957,348	$0.62M	0.1%	+57.4%	0.443%
1/30/2023	Welch Group LLC	43,000	$28K	0.0%	-26.7%	0.020%
1/9/2023	Addison Capital Co	15,870	$2.32M	1.5%	N/A	0.007%
11/15/2022	Laurion Capital Management LP	4,220,500	$7.26M	0.0%	-1.6%	1.952%
11/15/2022	Magnolia Capital Advisors LLC	418,569	$0.72M	0.6%	+25.1%	0.194%
11/15/2022	Boxer Capital LLC	1,500,000	$2.58M	0.1%	N/A	0.694%
11/15/2022	Caxton Associates LP	311,974	$0.54M	0.1%	+209.8%	0.144%
11/14/2022	Zacks Investment Management	44,550	$77K	0.0%	N/A	0.021%
11/14/2022	Tudor Investment Corp Et Al	39,374	$68K	0.0%	-88.1%	0.018%
11/14/2022	Cubist Systematic Strategies LLC	349,867	$0.60M	0.0%	+4,589.3%	0.162%
11/14/2022	Ergoteles LLC	485,434	$0.84M	0.0%	-48.2%	0.225%
11/14/2022	E Fund Management Co. Ltd.	15,167	$26K	0.0%	N/A	0.007%
11/7/2022	Virtu Financial LLC	74,592	$0.13M	0.0%	N/A	0.035%
11/3/2022	Mutual Advisors LLC	22,095	$38K	0.0%	-40.4%	0.010%
11/3/2022	Barclays PLC	136,136	$0.23M	0.0%	N/A	0.063%
10/31/2022	Concorde Asset Management LLC	35,500	$61K	0.1%	N/A	0.016%
10/31/2022	Green Square Capital Advisors LLC	1,080,000	$1.86M	0.3%	N/A	0.500%
10/26/2022	Belvedere Trading LLC	66,493	$78K	0.0%	N/A	0.031%
10/24/2022	ACT Wealth Management LLC	38,476	$66K	0.0%	N/A	0.018%
10/17/2022	SevenBridge Financial Group LLC	20,000	$34K	0.0%	N/A	0.009%
10/14/2022	Private Advisor Group LLC	119,374	$0.21M	0.0%	N/A	0.055%
10/13/2022	Chiron Capital Management LLC	116,860	$0.20M	0.1%	N/A	0.054%
10/13/2022	Welch Group LLC	58,700	$0.10M	0.0%	N/A	0.027%
10/11/2022	Sugarloaf Wealth Management LLC	79,050	$0.14M	0.0%	N/A	0.037%
10/4/2022	AdvisorNet Financial Inc	42,329	$73K	0.0%	N/A	0.020%
8/16/2022	Discovery Capital Management LLC CT	14,125,079	$17.52M	2.3%	N/A	6.541%
8/15/2022	Laurion Capital Management LP	4,289,193	$5.32M	0.1%	N/A	1.986%
8/15/2022	Kettle Hill Capital Management LLC	344,400	$0.43M	0.1%	N/A	0.159%
8/12/2022	Commerce Bank	459,000	$0.57M	0.0%	N/A	0.213%
8/10/2022	Synovus Financial Corp	33,000	$41K	0.0%	N/A	0.015%
8/8/2022	Nicolet Advisory Services LLC	21,500	$30K	0.0%	N/A	0.010%
8/8/2022	Oppenheimer & Co. Inc.	45,500	$56K	0.0%	N/A	0.021%
8/8/2022	Y Intercept Hong Kong Ltd	25,079	$31K	0.0%	N/A	0.012%
8/5/2022	Gamble Jones Investment Counsel	61,000	$76K	0.0%	N/A	0.028%
8/5/2022	Horizon Kinetics Asset Management LLC	34,000	$42K	0.0%	N/A	0.016%
8/4/2022	Steward Partners Investment Advisory LLC	36,106	$45K	0.0%	N/A	0.017%
8/3/2022	CIBC Private Wealth Group LLC	41,490	$51K	0.0%	N/A	0.019%
8/3/2022	Stephens Inc. AR	25,162	$31K	0.0%	N/A	0.012%
8/3/2022	Janney Montgomery Scott LLC	82,412	$0.10M	0.0%	N/A	0.038%

Data available starting January 2016

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor engine. The company has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

Today's Range

Now: $1.13

$1.07

$1.20

50 Day Range

MA: $1.72

$1.09

$2.35

52 Week Range

Now: $1.13

$0.66

$10.47

Volume

7,071 shs

Average Volume

187,283 shs

Market Capitalization

$18.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Alaunos Therapeutics?: Alaunos Therapeutics' top insider investors include:
Robert W Postma (Director)
Kevin S Sr Boyle (CEO)
Learn More about top insider investors at Alaunos Therapeutics.

This Apple-like Innovator is Revolutionizing Healthcare

From Wall Street Star | Ad

Click here to learn more about the booming eHealth industry

TCRT Insider Trading

Alaunos Therapeutics Insider Trading History Chart

Alaunos Therapeutics Share Price & Price History

Alaunos Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Alaunos Therapeutics (NASDAQ:TCRT)